A low-cost and widely available drug, termed tranexamic acid, could reduce deaths from traumatic brain injury by ‘hundreds of thousands’, according to a recent study.
Researchers have suggested that traumatic microbleeds may be a form of injury to brain blood vessels that could predict worse outcomes following a head injury.
A recently published study has indicated that eliminating microglia could significantly reduce tau-linked brain damage in mice, providing a path for novel treatments.
Researchers have discovered that more women and less men are diagnosed with amnestic mild cognitive impairment when sex-specific scores are used.
Wireless brain–machine interface technology has been utilized to design an exoskeleton for helping a tetraplegic patient move his limbs.
By manipulating molecular models, researchers discover protein that could accelerate recovery from peripheral nerve injury.
In a recent follow-up study, researchers discovered that when used as a dietary supplement, choline was able to reduce symptoms associated with Alzheimer’s disease in female mice.
For the first time in living animals, researchers have tracked the movement and functional activity of neurons as they wired together into circuits and discovered that motor neurons are the first to send signals.
A recent study has demonstrated that circadian rhythms in mice may control the extent of response to vaccination of CD8 T cells to antigen presentation by dendritic cells.
Epidyolex® has gained approval from the European Commission for seizures associated with Lennox–Gastaut syndrome or Dravet syndrome in patients 2 years of age and older.